Correlation Between Kibush Capital and Bristol-Myers Squibb

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kibush Capital and Bristol-Myers Squibb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kibush Capital and Bristol-Myers Squibb into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kibush Capital Corp and Bristol-Myers Squibb, you can compare the effects of market volatilities on Kibush Capital and Bristol-Myers Squibb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kibush Capital with a short position of Bristol-Myers Squibb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kibush Capital and Bristol-Myers Squibb.

Diversification Opportunities for Kibush Capital and Bristol-Myers Squibb

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kibush and Bristol-Myers is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Kibush Capital Corp and Bristol-Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol-Myers Squibb and Kibush Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kibush Capital Corp are associated (or correlated) with Bristol-Myers Squibb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol-Myers Squibb has no effect on the direction of Kibush Capital i.e., Kibush Capital and Bristol-Myers Squibb go up and down completely randomly.

Pair Corralation between Kibush Capital and Bristol-Myers Squibb

Given the investment horizon of 90 days Kibush Capital Corp is expected to generate 11.4 times more return on investment than Bristol-Myers Squibb. However, Kibush Capital is 11.4 times more volatile than Bristol-Myers Squibb. It trades about 0.1 of its potential returns per unit of risk. Bristol-Myers Squibb is currently generating about 0.22 per unit of risk. If you would invest  0.03  in Kibush Capital Corp on September 10, 2022 and sell it today you would earn a total of  0.00  from holding Kibush Capital Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kibush Capital Corp  vs.  Bristol-Myers Squibb

 Performance (%) 
       Timeline  
Kibush Capital Corp 
Kibush Performance
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Kibush Capital Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady fundamental indicators, Kibush Capital reported solid returns over the last few months and may actually be approaching a breakup point.

Kibush Price Channel

Bristol-Myers Squibb 
Bristol-Myers Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol-Myers Squibb are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain primary indicators, Bristol-Myers Squibb displayed solid returns over the last few months and may actually be approaching a breakup point.

Bristol-Myers Price Channel

Kibush Capital and Bristol-Myers Squibb Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kibush Capital and Bristol-Myers Squibb

The main advantage of trading using opposite Kibush Capital and Bristol-Myers Squibb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kibush Capital position performs unexpectedly, Bristol-Myers Squibb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will offset losses from the drop in Bristol-Myers Squibb's long position.
Kibush Capital vs. Eutelsat Communications SA
Kibush Capital vs. ADTRAN Inc
Kibush Capital vs. ATT Inc ELKS
Kibush Capital vs. Ubiquiti Networks
The idea behind Kibush Capital Corp and Bristol-Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Bristol-Myers Squibb vs. Caterpillar
Bristol-Myers Squibb vs. Bank Of America
Bristol-Myers Squibb vs. ATT Inc
Bristol-Myers Squibb vs. Cisco Systems
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go